SCHOFIELD, Wis., Feb. 23, 2010 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS), a pharmaceutical company engaged in the development and marketing of a line of revolutionary, new, non-prescription medicines that treat migraine headaches, insomnia and tension-type headaches under the brand name LipiGesic™, announced today that it has received approval to run its direct response television commercials featuring its non-prescription migraine medication LipiGesic™ M on major cable networks.
